High-risk smoldering myeloma – a case for early intervention?
We need more high-quality evidence in post-SLiM-CRAB SMM cohort to better identify the subset of patients most likely to benefit from early intervention. Treatment approaches should be refined considering patient preferences and maintaining quality of life (QoL).
Authors
- Karthik Ramasamy (ORCID: https://orcid.org/0000-0003-3385-3707)
- A. Krishnamoorthi
- Rohit Vijjhalwar (ORCID: https://orcid.org/0000-0003-1283-7839)
- Arun Kannan (ORCID: https://orcid.org/0000-0001-8750-230X)
Institutions
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Oxford (GB)
- Oxford University Hospitals NHS Trust (GB)
Publication Details
- Journal
- Current Opinion in Oncology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1097/cco.0000000000001182
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00